Trials / Conditions / Sickling Disorder Due to Hemoglobin S
Sickling Disorder Due to Hemoglobin S
5 registered clinical trials studyying Sickling Disorder Due to Hemoglobin S — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | 131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Dise NCT07015684 | Columbia University | Phase 1 |
| Recruiting | A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD NCT04201210 | University of Regensburg | Phase 2 |
| Completed | Comparison of Two Methods of Transfusion for Stroke Prevention in Sickle Cell NCT02561312 | Chattanooga-Hamilton County Hospital Authority | — |
| Terminated | Effects of HQK-1001 in Patients With Sickle Cell Disease NCT01601340 | HemaQuest Pharmaceuticals Inc. | Phase 2 |
| Completed | A Study of HQK-1001 in Patients With Sickle Cell Disease NCT01322269 | HemaQuest Pharmaceuticals Inc. | Phase 2 |